These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 7292020)
1. Advances in the use of therapeutic pheresis for the management of rheumatic diseases. Wallace DJ; Goldfinger D; Thompson-Breton R; Martin V; Lowe CM; Bluestone R; Klinenberg JR Semin Arthritis Rheum; 1980 Nov; 10(2):81-91. PubMed ID: 7292020 [TBL] [Abstract][Full Text] [Related]
2. Plasmapheresis and lymphoplasmapheresis in the management of rheumatoid arthritis. Wallace DJ; Goldfinger D; Gatti R; Lowe C; Fan P; Bluestone R; Klinenberg JR Arthritis Rheum; 1979 Jul; 22(7):703-10. PubMed ID: 454499 [TBL] [Abstract][Full Text] [Related]
3. Plasmapheresis in rheumatic diseases. Wallace DJ Biomed Pharmacother; 1986; 40(8):284-6. PubMed ID: 3493039 [TBL] [Abstract][Full Text] [Related]
4. Current status of therapeutic apheresis in rheumatoid arthritis. Wallace DJ; Goldfinger D; Klinenberg JR Artif Organs; 1981 Aug; 5(3):297-8. PubMed ID: 7305692 [TBL] [Abstract][Full Text] [Related]
5. Plasmapheresis in collagen vascular diseases. Lewis EJ Ther Apher; 1999 May; 3(2):172-7. PubMed ID: 10341393 [No Abstract] [Full Text] [Related]
6. Exercise for Athletes With Inflammatory Arthritis. Powell AP; English J Curr Sports Med Rep; 2018 Sep; 17(9):302-307. PubMed ID: 30204634 [TBL] [Abstract][Full Text] [Related]
7. [Rheumatology: Progress in Diagnosis and Treatments Topics: IV. Collagen Diseases Except for Rheumatoid Arthritis and Hot Topics; 1. Systemic lupus erythematosus]. Tamura N Nihon Naika Gakkai Zasshi; 2014 Oct; 103(10):2465-72. PubMed ID: 27514195 [No Abstract] [Full Text] [Related]
8. Lymphocyte transformation to connective tissue antigens in adult and juvenile rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, systemic lupus erythematosus, and a nonarthritic control population. Golds EE; Stephen IB; Esdaile JM; Strawczynski H; Poole AR Cell Immunol; 1983 Nov; 82(1):196-209. PubMed ID: 6640674 [TBL] [Abstract][Full Text] [Related]
9. Short and longterm experience with plasmapheresis in connective tissue diseases. Dequeker J; Geusens P; Wielands L Biomedicine; 1980 Dec; 32(4):189-94. PubMed ID: 7470581 [TBL] [Abstract][Full Text] [Related]
10. Plasma exchange--a new approach to immune modulation in rheumatic diseases. Cardella CJ J Rheumatol; 1979; 6(6):606-9. PubMed ID: 160939 [No Abstract] [Full Text] [Related]
11. Diagnostic, prognostic and therapeutic aspects of systemic lupus erythematosus and rheumatoid arthritis. Weyand C Klin Wochenschr; 1990; 68 Suppl 21():55-63. PubMed ID: 2198390 [TBL] [Abstract][Full Text] [Related]
12. Intense immunosuppression and stem-cell transplantation for patients with severe rheumatic autoimmune disease: a review. Van Laar JM; Tyndall A Cancer Control; 2003; 10(1):57-65. PubMed ID: 12598856 [TBL] [Abstract][Full Text] [Related]
13. The connective tissue diseases and the overall influence of gender. Lahita RG Int J Fertil Menopausal Stud; 1996; 41(2):156-65. PubMed ID: 8829695 [TBL] [Abstract][Full Text] [Related]
14. Membrane plasmapheresis and its current possibilities in internal medicine. Zadrazil J; Vykydal M; Konecný K Acta Univ Palacki Olomuc Fac Med; 1987; 117():185-93. PubMed ID: 2977688 [No Abstract] [Full Text] [Related]
15. [The unresolved problems of plasmapheresis]. Vorob'ev AI; Gorodetskiĭ VM; Iakhnina EI Ter Arkh; 1994; 66(1):4-8. PubMed ID: 8146792 [No Abstract] [Full Text] [Related]
16. Anticyclic citrullinated peptide antibodies in rheumatoid and nonrheumatoid rheumatic disorders: experience with 1162 patients. Payet J; Goulvestre C; Bialé L; Avouac J; Wipff J; Job-Deslandre C; Batteux F; Dougados M; Kahan A; Allanore Y J Rheumatol; 2014 Dec; 41(12):2395-402. PubMed ID: 25274898 [TBL] [Abstract][Full Text] [Related]